Scimago Journal & Country Rank

You must have one of these extentions in you browser

AdBlock, AdBlock Plus, uBlock Origin or others
  1. Go to your browser extentions and click the Ad blocker icon
  2. Select pause on this site, don't run on pages on this site, or some other similar option.
  3. Now you can refresh the page

Drug Development and Registrationopen access

Country

Russian Federation

Universities and research institutions in Russian Federation
Media Ranking in Russian Federation

Subject Area and Category

Publisher

Center of Pharmaceutical Analytics

H-Index

7

Publication type

Journals

ISSN

23052066, 26585049

Coverage

2019-2023

Information

Homepage

How to publish in this journal

Scope

Research and production peer-reviewed journal «Drug development & registration» (Razrabotka i registraciâ lekarstvennyh sredstv) is an up-to-date quarterly free application publication and information portal for Professionals involved in the circulation of medicines. Journal is designed for pharmaceutical manufacturers and their employees from the departments of development, quality control, registration, production and development; employees of laboratory centers, contract research organizations, scientific and educational institutions. The main focus of the journal is to summarize scientific and practical achievements in the field of drug development and registration, to increase the scientific and practical qualifications of specialists in the field of drug circulation. The main five thematic sections of the journal «Drug development & registration» (Razrabotka i registraciâ lekarstvennyh sredstv) include the development lifecycle of a drug product from its creation to obtaining a marketing authorization. The first section is devoted to the research and development of new medicines, the second one provides information about pharmaceutical technology, pharmaceutical ingredients, and equipment for drug development. The third section describes analytical quality control methods; the fourth section is devoted to approaches to evaluating the efficacy and safety of medicines, conducting clinical and preclinical studies. The fifth section deals with the validation of methods, preparation of the registration dossier, the life cycle of the drug product in the GxP environment. Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Drug Discovery2021Q4
Drug Discovery2022Q4
Drug Discovery2023Q4
Pharmaceutical Science2021Q3
Pharmaceutical Science2022Q3
Pharmaceutical Science2023Q3
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20210.156
20220.191
20230.187
Total Documents

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

YearDocuments
201956
202075
202199
2022113
2023125
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20190.000
Cites / Doc. (4 years)20200.304
Cites / Doc. (4 years)20210.740
Cites / Doc. (4 years)20220.709
Cites / Doc. (4 years)20230.682
Cites / Doc. (3 years)20190.000
Cites / Doc. (3 years)20200.304
Cites / Doc. (3 years)20210.740
Cites / Doc. (3 years)20220.709
Cites / Doc. (3 years)20230.714
Cites / Doc. (2 years)20190.000
Cites / Doc. (2 years)20200.304
Cites / Doc. (2 years)20210.740
Cites / Doc. (2 years)20220.753
Cites / Doc. (2 years)20230.802
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20190
Self Cites20207
Self Cites202135
Self Cites202254
Self Cites202388
Total Cites20190
Total Cites202017
Total Cites202197
Total Cites2022163
Total Cites2023205
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20190
External Cites per document20200.179
External Cites per document20210.473
External Cites per document20220.474
External Cites per document20230.408
Cites per document20190.000
Cites per document20200.304
Cites per document20210.740
Cites per document20220.709
Cites per document20230.714
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
20191.79
20205.33
20214.04
20222.65
20234.80
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20190
Non-citable documents20200
Non-citable documents20211
Non-citable documents20224
Non-citable documents20238
Citable documents20190
Citable documents202056
Citable documents2021130
Citable documents2022226
Citable documents2023279
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20190
Uncited documents202045
Uncited documents202167
Uncited documents2022125
Uncited documents2023164
Cited documents20190
Cited documents202011
Cited documents202164
Cited documents2022105
Cited documents2023123
% Female Authors

Evolution of the percentage of female authors.

YearFemale Percent
201962.57
202063.45
202163.27
202262.79
202363.51
Documents cited by public policy (Overton)

Evolution of the number of documents cited by public policy documents according to Overton database.

DocumentsYearValue
Overton20190
Overton20200
Overton20210
Overton20220
Overton20230
Documents related to SDGs (UN)

Evolution of the number of documents related to Sustainable Development Goals defined by United Nations. Available from 2018 onwards.

DocumentsYearValue
SDG20199
SDG202016
SDG202118
SDG202227
SDG202328
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
SCImago Graphica
Explore, visually communicate and make sense of data with our new data visualization tool.
Metrics based on Scopus® data as of March 2024
Loading comments…

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2024. Data Source: Scopus®

Legal Notice

Privacy Policy